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An unusual Burkholderia gladioli double chain-initiating nonribosomal 
peptide synthetase assembles ‘fungal’ icosalide antibiotics†
Matthew Jenner,a, b‡ Xinyun Jian,a‡ Yousef Dashti,a Joleen Masschelein,a Christian Hobson,a Douglas 
M. Roberts,a Cerith Jones,d Simon Harris,e Julian Parkhill,e Huzefa A. Raja,f Nicholas H. Oberlies,f
Cedric J. Pearce,g Eshwar Mahenthiralingamd and Gregory L. Challisa, b, c* 
Burkholderia is a multi-talented genus of Gram-negative bacteria, which in recent years has become increasingly recognised 
as a promising source of bioactive natural products. Metabolite profiling of Burkholderia gladioli BCC0238 showed that it 
produces the asymmetric lipopeptidiolide antibiotic icosalide A1, originally isolated from a fungus. Genome sequencing of 
several B. gladioli isolates identified a gene encoding a nonribosomal peptide synthase (NRPS) with an unsual architecture 
that was predicted to be responsible for icosalide biosynthesis. Inactivation of this gene in B. gladioli BCC0238 abolished 
icosalide production. PCR analysis and sequencing of total DNA from the orginal fungal icosalide A1 producer revealed it has 
a B. gladioli strain associated with it that harbours an NRPS with an identical arcitecture to that responsible for icosalide A1 
assembly in B. gladioli BCC0238. Sequence analysis of the icosalide NRPS indicated that it contains two chain-initiating 
condensation (CI) domains. One of these is appended to the N-terminus of module 1 – a common archictecture for NRPSs 
involved in lipopeptide assembly. The other is embedded in module 3, immediately downstream of a putative chain-
elongating condensation domain. Analysis of the reactions catalysed by a tridomain construct from module 3 of the NRPS 
using intact protein mass spectometry showed that the embedded CI domain initiates assembly of a second lipopetide chain, 
providing key insights into the mechanism for asymmetric diolide assembly. 
Introduction 
Bacteria belonging to the Burkholderia genus thrive in various 
ecological niches, ranging from the plant rhizosphere to the human 
lung, and play critical roles in ecological interactions often through 
the secretion of specialised metabolites1,2. The metabolic arsenal of 
these bacteria is employed to eliminate other bacterial competitors 
and supress plant pathogenic fungi and nematodes. In recent years 
various Burkholderia species have been shown to produce numerous 
specialised metabolites, many of which are assembled by polyketide 
synthases (PKSs) and nonribosomal peptide synthetases (NRPSs) 
biosynthetic assembly lines3. Notable examples include: the 
respiratory toxin bongkrekic acid4; anti-proliferative agents such as 
thailanstatin and spliceostatin5,6; and the antibiotics enacyloxin IIa 
and gladiolin7,8.
Burkholderia  participate in both antagonistic and mutualistic 
interactions with fungi. Much of the antagonistic behaviour can 
be attributed to an array of antifungal compounds secreted by 
many Burkholderia species9–12. However, it has also been 
reported that Burkholderia strains have beneficial effects on 
fungi, suggestive of symbiotic, or at least mutualistic 
interactions13–15. The exemplar study of this relationship is the 
symbiotic pairing of Burkholderia rhizoxinica (since reclassified 
as Paraburkholderia rhizoxinica) and the rice seedling blight 
pathogen Rhizopus microspores. B. rhizoxinica was identified as 
the producer of the antimitotic macrolide rhizoxin, the 
causative agent of rice seedling blight10,16.  
In a preliminary communication, we disclosed that 
Burkholderia gladioli isolates from cystic fibrosis (CF) patients 
produce icosalide A1 (1)17, a lipopeptodiolide antibiotic 
originally isolated from a fungus18. We also showed that a 
nonribosomal peptide synthetase (NRPS) with an unusual 
architecture is responsible for icosalide A1 assembly17. 
Subsequently, Hertweck and co-workers reported that a B. 
gladioli endosymbiont of a beetle, along with several other 
Burkholderia species from diverse sources, also produce 
icosalide A1 and showed that an NRPS with same unusual 
architecture as that identified in the CF isolates is responsible 
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for its biosynthesis19. Here we provide a full account of our work 
and show that a B. gladioli strain containing the icosalide A1 
NRPS is associated with the originally reported fungal producer. 
Moreover, we demonstrate that a chain-initiating condensation 
(CI) domain embedded in the middle of the icosalide A1 NRPS 
selectively N-acylates a serinyl thioester covalently attached to 
the downstream peptidyl carrier protein (PCP) domain with a 
(3R)-3-hydroxydecanoyl panthetheine thioester, providing a 
mechanistic rationale for asymmetric lipopeptidiolide 
formation.  
Results and discussion 
We recently reported the discovery of gladiolin, a novel 
macrolide antibiotic with promising activity against 
Mycobacterium tuberculosis (MIC = 0.4 µg/mL) and low 
mammalian cell cytotoxicity, from B. gladioli BCC0238 (LMG-
P26202)7. In the course of investigations of other specialised 
metabolites produced by this cystic fibrosis clinical isolate using 
UHPLC-ESI-Q-TOF-MS, compounds with the molecular formulae 
C36H64N4O10 and C34H60N4O10 were observed (Figs S1 and S2†). 
These molecular formulae correspond to a set of three 
Fig. 1. Structures of the icosalides, identification of the NRPS-encoding gene responsible for icosalide biosynthesis in B. gladioli BCC0238 
and phylogenetic comparison of the recA sequence amplified from total DNA of the Aureobasidium sp. originally reported to produce 
icosalide A1 with various Burkholderia species. (A) Structures of icosalides A1 (1), A2 (2) and B (3). (B) Schematic representation of the 
~500 kDa NRPS encoded by the ~15 kb icoA gene. Domain abbreviations are as follows: C, condensation; A, adenylation; PCP, peptidyl 
carrier protein; TE, thioesterase. (C) Extracted ion chromatogram at m/z 713.46 ± 0.02, corresponding to [M+H]+ for icosalide A1, from LC-
MS analyses of extracts of agar-grown cultures of B. gladioli BCC0238 (top) and B. gladioli BCC0238 ΩicoA, in which the NRPS-encoding 
gene has been disrupted (bottom). (D). Phylogenetic comparison of the recA sequence amplified from the total DNA extract of 
Aureobasidium sp. MSX 59166 (labelled ‘icosalide producer’) with recA sequences from 24 representative Burkholderia species, showing 
that the fungus-associated bacterium clades with Burkholderia gladioli. The scale bar indicates the number of substitutions per site.
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structurally-related lipopeptidiolides, known as icosalides A1 
(1), A2 (2) and B (3), reported to be produced by fungi18 (Fig. 
1A). 
The icosalides possess similar 20-membered lipopeptidiolide 
structures consisting of two serine, leucine and 3-hydroxy acid 
residues. In icosalide A1 (1), one of the leucine residues is D-
configured, whereas all of the amino acid residues in icosalides 
A2 (2) and B (3) are L-configured. Icosalides A1 (1) and A2 (2) 
both contain one eight-carbon and one ten-carbon 3-hydroxy 
acid residue, whereas icosalide B (3) contains two eight-carbon 
3-hydroxy acid residues. The incorporation of a D-leucine 
residue into icosalide A1 (1) has a dramatic effect on its 
biological activity. While icosalide A1 (1) is active against 
Streptococcus pyogenes (MIC: 8 - 16 µg/mL), icosalides A2 (2) 
and B (3) do not show any antibacterial activity but are cytotoxic 
towards replicating MDCK cells (CC50: 5 µg/mL)18. 
The compound with the molecular formula C36H64N4O10 was 
purified using semi-preparative HPLC and its planar structure 
was shown to be identical to that of icosalide A1 (1) and A2 (2) 
using a combination of 1H, 13C and HMBC NMR experiments (Fig. 
S3 and Table S1†). The absolute stereochemistry of the amino 
acid residues in the purified compound was determined via 
saponification of the esters, followed by semi-preparative HPLC 
purification and MS analysis of the resulting pair of 3-
hydroxyacyl-dipeptides, acid hydrolysis to liberate the 
constituent amino acids, derivatisation using Marfey’s reagent 
and comparison with the corresponding L and D-configured 
leucine and serine standards (Fig. S4 and S5†). This revealed 
that the Leu-2 residue is D-configured, confirming the identity of 
the metabolite produced by B. gladioli as icosalide A1 (1). The 
production level of the compound with the molecular formula 
C34H60N4O10 was too low to permit characterisation by NMR 
spectroscopy (Fig. S6†), but it seems likely that this has the same 
planar structure as icosalide B (3). The activity of purified 
icosalide A1 (1) against several Gram-positive and Gram-
negative bacteria, including the ESKAPE panel of pathogens, and 
Candida albicans was tested. Modest activity against E. faecium 
(MIC: 16 µg/mL) was observed (Table S2†).   
Inspection of putative specialised metabolite biosynthetic 
gene clusters in the previously reported genome sequence of B. 
gladioli BCC0238,7 identified a single ~15 kb gene (icoA) on 
chromosome 2 encoding a nonribosomal peptide synthetase 
(NRPS) with the requisite module and domain organisation for 
icosalide assembly (Fig. 1B). This NRPS contains four 
adenylation (A) domains, two of which are predicted to be 
specific for L-Leucine and two for L-Serine20 (Table S3†). It also 
contains five condensation (C) domains and a thioesterase (TE) 
domain, which together account for the four amide and two 
ester bond-forming reactions required to assemble the 
lipopeptidiolide structure of the icosalides21 (Fig. 2A). We 
identified icoA in the genomes of several other B. gladioli
isolates (BCC0252, BCC1677, BCC1698 and BCC1720), all of 
which were shown to produce icosalide A1 (1). In contrast, no 
icosalide A1 (1) production was detected in B. gladioli BCC1713 
(Fig. S7†), which is lacking icoA. These data are consistent with 
the hypothesis that the NRPS encoded by icoA is responsible for 
icosalide biosynthesis. To verify this, we inactivated the icoA
gene in B. gladioli BCC0238 using insertional mutagenesis. 
UHPLC-ESI-Q-TOF-MS analysis of extracts from the icoA mutant 
confirmed that it is no longer able to produce icosalides (Fig. 
1C). 
Icosalide A1 (1) was originally isolated from extracts of an 
Aureobasidium species fungus (strain MSX 59166), whereas 
icosalides A2 (2) and B (3) were isolated from a second less well 
characterized fungal species (MSX 74159)18. The data presented 
above suggested that B. gladioli bacteria associated with these 
fungi might be the true producers of the icosalides isolated from 
them. To investigate this hypothesis, total DNA from the 
originally reported icosalide A1 (1) producer, Aureobasidium sp. 
MSX 59166, was screened by PCR for orthologues of icoA and 
the bacterial housekeeping gene recA. In both cases, we 
obtained amplimers of the expected size (Fig. S8†), confirming 
that a bacterium, likely harbouring an icoA orthologue, is 
associated with the fungus. Burkholderia species can be 
unambiguously identified via phylogenetic comparison of their 
Fig. 2. Proposed mechanism for assembly of icosalide A1 (1) by 
IcoA.  Domain and module organisation of the NRPS, showing the 
PCP-bound thioester intermediates proposed to be formed by 
each module. The CI domains initiate lipopeptide chain assembly 
by N-acylating the aminoacyl thioesters attached to the 
downstream PCP domains with 3-hydroxyacyl thioester 
intermediates in fatty acid biosynthesis. Abbreviations are as 
follows: A, adenylation domain; CI, chain initiating condensation 
domain; CE, bifuctional epimerisation-condensation domain; LCL, 
condensation domain that catalyses condensation of L-
configured aminoacyl donor and acceptor substrates; PCP, 
peptidyl carrier protein domain; TE, thioesterase domain. The 
residues used to predict the substrate specificity of A-domains 
are shown in Table S3†.
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recA sequences22. Thus, we compared the sequence of the recA
amplimer with the sequences of recA genes from 25 
representative Burkholderia species. This showed that the 
Aureobasidium-associated bacterium is B. gladioli (Fig. 1D). 
Illumina sequencing of the total DNA from the Aureobasidium
sp. allowed an approximately 1 Mb contiguous sequence of 
bacterial DNA, encompassing the icoA orthologue, to be 
assembled (Fig. S9†). Comparison of this contiguous sequence 
with the corresponding region of the B. gladioli BCC0238 
genome showed a high degree of synteny (Fig. S9†), confirming 
that the Aureobasidium sp. harbours a B. gladioli strain 
containing an icoA orthologue. Although a Gram-negative 
bacterium could be isolated from the Aureobasidium sp., it 
quickly lost viability and was not identifiable. 
Inspection of the structure of icosalide A1 (1) suggests it is 
assembled via initial formation of 3-hydroxyoctanoyl-D-leucinyl-
L-serinyl and 3-hydroxydecanoyl-L-serinyl-L-leucinyl thioesters, 
which are joined via a pair of ester linkages to form the 
lipopeptidiolide. To gain insight into the role played by each of 
the five C domains of IcoA in the biosynthesis icosalide A1 (1), 
we carried out phylogenetic analyses23. These indicated that the 
first and fourth domains group with chain initiating (CI) 
domains, which are typically located at the N-terminus of the 
first module in NRPSs responsible for lipopeptide biosynthesis 
and initiate chain assembly via N-acylation of the amino acyl 
Fig. 3. In vitro reconstitution of aminoacyl thioester formation and N-acylation by the CI-A-PCP tridomain from module 3 of IcoA.
Deconvoluted mass spectra of IcoA module 3 CI-A-PCP tri-domain. (A) Resulting from incubation with ATP, L-Ser and (3R)-3-hydroxyoctanoyl 
(top), (3R)-3-hydroxydecanoyl (middle), or (3R)-3-hydroxyoctanoyl and (3R)-3-hydroxydecanoyl (bottom) pantetheine thioesters. (B) 
Following incubation with ATP, L-Ser and (3S)-3-hydroxyoctanoyl (top), or (3S)-3-hydroxydecanoyl (bottom) pantetheine thioesters. (C) 
Resulting from incubation of the H164A mutant with ATP, L-Ser and (3R)-3-hydroxyoctanoyl (top), or (3R)-3-hydroxydecanoyl (bottom) 
pantetheine thioesters. Dashed lines indicate the peaks corresponding to each condensed species, and the holo- and L-Ser-loaded species 
are labelled as indicated in the bottom right corner. Loading of L-Ser onto the PCP domain results in an 87 Da mass increase.  For the wild 
type IcoA CI-A-PCP tri-domain, N-acylation of the serinyl-PCP thioester with the (3R)-3-hydroxyoctanoyl and (3R)-3-hydroxydecanoyl 
thioesters resulted in additional 142 and 170 Da mass increases, respectively. Analogous mass increases were observed when the (3S)-3-
hydroxyoctanoyl and (3S)-3-hydroxydecanoyl thioesters were used, but the levels of product formation were lower, indicating that the CI
domain prefers R-configured 3-hydroxyacyl thioesters. A small amount of product formation was observed when the H164A mutant of the 
IcoA CI-A-PCP tri-domain was used in place of the wild type protein, due to uncatalysed N-acylation of the serinyl thioester with the (3R)-3-
hydroxyoctanoyl and (3R)-3-hydroxydecanoyl thioesters. 
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thioester bound to the downstream PCP domain with a fatty 
acyl thioester. The third and fifth C domains of IcoA belong to 
the LCL group, which catalyse formation of a peptide bond 
between L-configured amino acyl thioesters attached to the 
upstream and downstream PCP domains. In contrast, the 
second C domain of IcoA clusters with bifunctional 
epimerisation-condensation (CE) domains, which catalyse 
epimerisation of the α-carbon in the aminoacyl thioester 
attached to the upstream PCP domain, followed by 
condensation of the resulting D-configured intermediate with 
an L-aminoacyl thioester attached to the downstream PCP 
domain. These C domain functional assignments led us to 
propose that modules 1 and 2 of IcoA are responsible for 
assembly of the 3-hydroxyoctanoyl-D-leucinyl-L-serinyl thioester 
intermediate in icosalide A1 (1) biosynthesis (Fig. 2). The CI
domain appended to the N-terminus of module 1 initiates chain 
assembly via N-acylation of the L-leucinyl thioester attached to 
the module 1 PCP domain with a 3-hydroxyoctanoyl thioester, 
likely donated by the primary metabolic fatty acid synthase 
(FAS). The C-domain in module 2 then catalyses epimerisation 
of the resulting N-acyl-leucinyl thioester, followed by 
condensation with the L-serinyl thioester attached to the PCP 
module 2 PCP domain. Module 3 of IcoA is very unusual, 
because it contains an LCL domain directly followed by a CI
domain. We hypothesize that the CI domain in this module 
catalyses a second chain initiation event, resulting in N-
acylation of the L-serinyl thioester attached to the downstream 
PCP domain with a 3-hydroxydecanoyl group, again likely 
provided by the primary metabolic FAS. The LCL domain then 
catalyses acylation of the hydroxyl group in the resulting 3-
hydroxydecanoyl-L-serinyl thioester with the 3-
hydroxyoctanoyl-D-leucinyl-L-serinyl thioester attached to the 
module 2 PCP domain. Elongation of the resulting intermediate 
with the L-leucinyl thioester attached to the PCP domain in 
module 4, catalysed by the upstream LCL domain, followed by 
lactonisation catalysed by the downstream TE domain, yields 
icosalide A1 (Fig. 2). 
To the best of our knowledge, initiation of chain assembly by 
an embedded CI domain like the one found in module 3 of IcoA 
is without precedent in NRPS enzymology. We thus sought to 
experimentally validate the proposed chain initiation reaction 
in vitro by overproducing the CI-A-PCP tri-domain from module 
3 of IcoA in E. coli. The resulting N-terminal His6 fusion protein, 
was purified to homogeneity using immobilised metal-ion 
affinity chromatography and the hexahistidine tag was cleaved 
using thrombin (Fig. S10†). ESI-Q-TOF-MS analysis showed that 
the PCP domain of this protein had been partially converted to 
the holo form by an E. coli phosphopantetheinyl transferase 
(Fig. S10†).  To fully convert the PCP domain into the holo form 
we incubated the protein with purified recombiant Sfp, a 
substrate tolerant phosphopantetheinyl transferase from B. 
subtilis,24 and coenzyme A.  
The holo-CI-A-PCP tri-domain was incubated with ATP, L-Ser 
and 3R-configured 3-hydroxyoctanoyl and 3-hydroxydecanoyl-
panthetheine thioesters, which mimic the (3R)-3-
hydroxyoctanoyl and (3R)-3-hydroxydecanoyl-ACP 
intermediates in fatty acid biosynthesis proposed to be 
intercepted by the CI domains in modules 1 and 3, respectively, 
of the NRPS. UHPLC-ESI-Q-TOF-MS analysis of the CI-A-PCP tri-
domain showed mass shifts consistent with the formation of 
serinyl, 3-hydroxyoctanoyl-serinyl and 3-hydroxydecanoyl-
serinyl PCP-thioesters (Fig. 3). When the CI-A-PCP tri-domain 
was replaced with a mutant containing an Ala residue in place 
of the active site His residue in the CI domain, only trace 
amounts of products were formed (Fig. 3).  
Icosalide A1 contains an N-((3R)-3-hydroxydecanoyl)-L-serine 
residue19. The module 3 CI domain is thus expected to accept 3-
hydroxydecanoyl thioesters in preference to 3-hydroxyoctanoyl 
thioesters. To test this hypothesis, we incubated the holo-CI-A-
PCP tri-domain with ATP, L-Ser and equimolar mixture of the 3R-
configured 3-hydroxyoctanoyl and 3-hydroxydecanoyl-
panthetheine thioesters. UHPLC-ESI-Q-TOF-MS analysis showed 
that only the product resulting from condensation with the 10-
carbon thioester is formed (Fig. 3).  The incorporation of 3-
hydroxyoctanoyl-L-serinyl-L-leucine into icosalide A2 (2), the 
major icosalide produced by the MSX 74159 fungus, suggests 
that the NRPS responsible for assembly of this metabolite 
contains an embedded CI domain with a preference for 8-
carbon thioesters. It would therefore be interesting to 
investigate the mechanisms underlying icosalide A2 
biosynthesis. 
The module 3 CI domain might also be expected to prefer R-
configured 3-hydroxyacyl thioesters to their S-configured 
counterparts. (Note, however, that the ketoreductase in 
bacterial fatty acid biosynthesis produces exclusively 3R-
configured 3-hydroxyacyl-ACP thioester intermediates25. There 
may therefore be no selective pressure to drive the evolution of 
stereoselectivity in CI domains.) To investigate whether the 
module 3 CI domain is stereoselective, we incubated the holo-
CI-A-PCP tri-domain with ATP, L-Ser and (3S)-3-hydroxyoctanoyl 
or (3S)-3-hydroxydecanoyl-panthetheine thioesters. Although 
the reaction with the 10-carbon thioester resulted in a 
significant degree of product formation, it was clearly less 
efficient than the reaction with the corresponding 3R-
configured thioester. In contrast, only trace amounts of product 
were formed in the reaction employing the eight-carbon 
thioester. Thus, the CI domain appears to possess a moderate 
to high degree of stereoselectivity, depending on the carbon 
chain length of the substrate. Overall, our data show that the 
module 3 CI domain of IcoA plays a key role in initiating the 
assembly of the (3R)-3-hydroxydecanoyl-L-serinyl-L-leucinyl 
moiety of icosalide A1. 
Conclusions 
We have shown that the “fungal” antibiotic icosalide A (1), 
originally isolated from an Aureobasidium sp., is produced by a 
B. gladioli strain closely associated with the fungus. In addition, 
we have shown that B. gladioli isolates from a range of sources, 
including CF lung infections, mushroom rot and insects also 
produce this metabolite. Comparative genome sequence 
analysis coupled with genetic manipulation allowed 
identification of a gene encoding the NRPS responsible for 
icosalide A1 biosynthesis. The third module of this NRPS has a 
Page 5 of 7 Chemical Science
C
he
m
ic
al
S
ci
en
ce
A
cc
ep
te
d
M
an
us
cr
ip
t
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
5 
A
pr
il 
20
19
. D
ow
nl
oa
de
d 
on
 4
/2
5/
20
19
 3
:1
6:
41
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
DOI: 10.1039/C8SC04897E
ARTICLE Journal Name
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
very unusual architecture, containing a putative chain-initiating 
CI domain in addition to a chain elongating LCL domain. Intact 
protein mass spectrometry showed that this CI domain 
catalyses selective N-acylation of a serinyl thioester bound to 
the module 3 PCP domain with a (3R)-3-hydroxydecanoyl 
thioester. Thus, the asymmetric lipopeptidiolide core of 
icosalide A1 (1) is assembled by a unique mechanism involving 
two distinct chain initiation events on a single NRPS subunit.  
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Fungus-associated Burkholderia gladioli bacteria use a unique ‘dual-priming’ nonribosomal peptide 
synthetase to assemble icosalide A1.
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